Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NAUTNAUT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in NAUTILUS BIOTECHNOLOGY INC

GOLDMAN SACHS GROUP INC holds 252,751 shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), worth $472,644 as of 2026-Q2. The position was decreased (-35.3% shares).

Current Value

$472,644

Current Shares

252,751

Total Value Change

+$143,876

Total Shares Change

+57,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
252,751
-35.3%
$472,6440.0%$1.87
0
2026-Q1
Increased
390,768
+31.4%
$1.5M0.0%$2.41
32
2025-Q4
Increased
297,437
+152.7%
$580,0020.0%$1.91
39
2025-Q3
Decreased
117,716
-62.6%
$99,4580.0%$0.80
0
2025-Q2
Increased
314,938
+83.3%
$228,2980.0%$0.69
24
2025-Q1
Decreased
171,787
-12.2%
$147,9090.0%$0.89
0
2024-Q4
New
195,695
-
$328,7680.0%$1.67
33

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used